ArticleBiologics : targets & therapy2026

Beyond Eczema Control: Long-Term Outcomes of Dupilumab Therapy in Six Patients with Netherton Syndrome.

Kamila Zawadzińska-Halat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.